Seyedkazemi Setareh
CHIEF DEVELOPMENT OFFICER at Avalanche Biotechnologies, Inc.
- Sold, on record
- $18k
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 15, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Avalanche Biotechnologies, Inc.CHIEF DEVELOPMENT OFFICER
Sales by reason
0
Routine
1
Plan not stated
2
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale Avalanche Biotechnologies, Inc.Plan not statedSep 19, 2022 2022
Sold 6,058 shares at $1.07 ($6k)
Seyedkazemi Setareh, Chief Development Officer
Sold 11.2% of holdings ($58k position)47,875 shares leftFirst sale on recordFiling
- 2 Form 4 sale Avalanche Biotechnologies, Inc.No planSep 15, 2023 +361 days
Sold 6,201 shares at $1.52 ($9k)
Seyedkazemi Setareh, Chief Development Officer
No 10b5-1 planSold 11.5% of holdings ($82k position)47,674 shares leftFiling
- 3 Form 4 sale Avalanche Biotechnologies, Inc.No planMay 15, 2025 +608 days
Sold 924 shares at $2.00 ($2k)
Seyedkazemi Setareh, CHIEF DEVELOPMENT OFFICER
No 10b5-1 planSold 6.3% of holdings ($29k position)13,768 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | May 16, 2025 | Avalanche Biotechnologies, Inc. | CHIEF DEVELOPMENT OFFICER | Form 4 sale | 924 | $2k | 6.3% | No plan | SEC |
| Sep 15, 2023 | Sep 18, 2023 | Avalanche Biotechnologies, Inc. | Chief Development Officer | Form 4 sale | 6,201 | $9k | 11.5% | No plan | SEC |
| Sep 19, 2022 | Sep 21, 2022 | Avalanche Biotechnologies, Inc. | Chief Development Officer | Form 4 sale | 6,058 | $6k | 11.2% | Plan not stated | SEC |